# Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation

> **NCT00626652** · PHASE2 · COMPLETED · sponsor: **Sequel Pharmaceuticals, Inc** · enrollment: 153 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** K201 Injection

## Key facts

- **NCT ID:** NCT00626652
- **Lead sponsor:** Sequel Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2010-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626652, "Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00626652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*